Orthocell (ASX:OCC) Presentation, FNN Investor Event, September 2018, Sydney

Company Presentations

Orthocell Limited (ASX:OCC) Managing Director, Paul Anderson presents on advances in regenerative medicine, the company's product line up and commercialisation at FNN's Investor Event.

Key points:

- Relatively new field of medicine that seeks to repair injured or diseased tissue by harnessing the body’s own regenerative capabilities

- CelGro Soft tissue reconstruction platform medical device

- Ortho-ATI regeneration of tendons cell therapy

- Large unmet clinical need

- Optimised manufacturing capability

- Ageing population and rising musculoskeletal disorders

- Demand for safe, efficient and cost effective treatments

For more information, watch Managing Director, Paul Anderson present.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?